Centene Corporation Securities Lawsuit: Potential Recovery for Affected Investors

A class action securities lawsuit was filed against Centene Corporation, seeking to recover losses of shareholders who suffered alleged securities fraud between December 12, 2024, and June 30, 2025. The complaint alleged that defendants provided false and misleading statements about the company's enrollment and morbidity rates, leading to a significant decline in stock value. On July 1, 2025, Centene issued a press release withdrawing 2025 guidance, citing lower-than-expected market growth. The company's stock price plummeted from $56.65 to $33.78 on July 2, 2025, a decline of 40.4%.

Key Takeaways:

  • A class action securities lawsuit was filed against Centene Corporation, alleging securities fraud between December 12, 2024, and June 30, 2025.
  • The complaint alleges that defendants provided false and misleading statements about the company's enrollment and morbidity rates.
  • Centene's stock price declined dramatically after the company issued a press release withdrawing 2025 guidance on July 1, 2025.
  • The lawsuit seeks to recover losses of shareholders who were adversely affected by the alleged securities fraud.
  • In the analysis of the 2025 Health Insurance Marketplace, Centene's overall market growth across 22 states was lower than expected.
  • The Company stated that this preliminary analysis resulted in a reduction of its previously issued guidance to approximately $1.8 billion or an adjusted diluted EPS of $2.75.
  • Investors who suffered a loss in Centene stock during the relevant time frame may be eligible to seek a recovery by visiting https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=161333&wire=5&utm_campaign=11.
  • Levi & Korsinsky LLP, lead counsel for the case, has secured hundreds of millions of dollars for aggrieved shareholders and has a team of over 70 employees to serve their clients.

Statistics:

  • The lawsuit alleges securities fraud between December 12, 2024, and June 30, 2025.
  • Centene's stock price declined from $56.65 to $33.78 on July 2, 2025, a decline of 40.4%.
  • The company's 2025 guidance was reduced from the previously issued $2.75 adjusted diluted EPS to approximately $1.8 billion.

Sources:

  • [Newsfile Corp. - August 13, 2025]
  • https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=161333&wire=5&utm_campaign=11
  • https://www.newsfilecorp.com/release/262434